Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minassian, B. A.
Right arrow Articles by Scherer, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minassian, B. A.
Right arrow Articles by Scherer, S. W.
Neurology 2000;54:488
© 2000 American Academy of Neurology


Brief Communications

Identification of new and common mutations in the EPM2A gene in Lafora disease

Berge A. Minassian, MD, Leonarda Ianzano, PhD, Antonio V. Delgado-Escueta, MD and Stephen W. Scherer, PhD

From the Division of Neurology, Departments of Paediatrics (Dr. Minassian) and Genetics (Drs. Minassian, Ianzano, and Scherer), The Hospital for Sick Children and The University of Toronto, Canada; and the Comprehensive Epilepsy Program (Dr. Delgado-Escueta), Department of Neurology and Brain Research Institute, University of California, Los Angeles School of Medicine and West Los Angeles DVA Medical Center.

Address correspondence and reprint requests to Dr. Stephen W. Scherer, Department of Genetics, The Hospital for Sick Children and The University of Toronto, 555 University Ave., Toronto, Ontario, M5G 1X8, Canada.

Lafora disease is a teenage onset progressive myoclonus epilepsy caused by mutations in the EPM2A gene. In this report, we describe new mutations within EPM2A, review the known mutations to date to identify the most common, and describe three simple tests for prenatal and carrier screening.

Key words: Lafora disease—EPM2A—Laforin—Epilepsy—Mutation—EPM2B




This article has been cited by other articles:


Home page
NeurologyHome page
R.-M. Boustany, J. W. Britton, J. E. Parisi, and B. M. Keegan
A 23-year-old man with seizures and visual deficit
Neurology, January 1, 2008; 70(1): 73 - 78.
[Full Text] [PDF]


Home page
NeurologyHome page
H. Lohi, J. Turnbull, X. C. Zhao, S. Pullenayegum, L. Ianzano, M. Yahyaoui, M. A. Mikati, N. P. Quinn, S. Franceschetti, F. Zara, et al.
Genetic diagnosis in Lafora disease: Genotype-phenotype correlations and diagnostic pitfalls
Neurology, March 27, 2007; 68(13): 996 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Ganesh, N. Tsurutani, T. Suzuki, K. Ueda, K. L. Agarwala, H. Osada, A. V. Delgado-Escueta, and K. Yamakawa
The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain
Hum. Mol. Genet., September 15, 2003; 12(18): 2359 - 2368.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
S. F. Al Otaibi, B. A. Minassian, C. A. Ackerley, W. J. Logan, and S. Weiss
Unusual Presentation of Lafora's Disease
J Child Neurol, July 1, 2003; 18(7): 499 - 501.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
S. Ganesh, A. V. Delgado-Escueta, T. Suzuki, S. Francheschetti, C. Riggio, G. Avanzini, A. Rabinowicz, S. Bohlega, J. Bailey, M. E. Alonso, et al.
Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype
Hum. Mol. Genet., May 16, 2002; 11(11): 1263 - 1271.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Raben, M. Danon, N. Lu, E. Lee, L. Shliselfeld, A. V. Skurat, P. J. Roach, J.C. Lawrence Jr., O. Musumeci, S. Shanske, et al.
Surprises of genetic engineering: A possible model of polyglucosan body disease
Neurology, June 26, 2001; 56(12): 1739 - 1745.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Ganesh, K. L. Agarwala, K. Ueda, T. Akagi, K. Shoda, T. Usui, T. Hashikawa, H. Osada, A. V. Delgado-Escueta, and K. Yamakawa
Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes
Hum. Mol. Genet., September 1, 2000; 9(15): 2251 - 2261.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. A. Minassian, L. Ianzano, M. Meloche, E. Andermann, G. A. Rouleau, A. V. Delgado-Escueta, and S. W. Scherer
Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy
Neurology, August 8, 2000; 55(3): 341 - 346.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.